One company, BioLife4D, which develops and manufactures bio-printing technology, is focusing on printing biological components for use in repairing the human heart as stepping stones towards producing an entire printed transplantable heart. It believes there’s a multi-million dollar market for the various components, such as heart valves, that it will need to learn how to print along the way.
“But if you’re able to print a liver, you have nothing until you print the next entire liver,” says the company’s chief executive Steve Morris. “From a scientific standpoint you could also…